CD40 cross-linking enhances the immunogenicity of Burkitt's-lymphoma cell lines

Teresa Frisan, Daria Donati, L. Cervenák, Julia Wilson, Maria Grazia Masucci, Maria Teresa Bejarano

Research output: Article

6 Citations (Scopus)

Abstract

Epstein-Barr-virus (EBV)-positive Burkitt's-lymphoma (BL) cell lines are not recognized by EBV-specific T cells, due to their non-immunogenic phenotype and restricted expression of latent EBV genes. We tested whether triggering of CD40 can alter the phenotype of the tumor cells with regard to: (i) expression of surface markers, (ii) expression of viral antigens, (iii) presentation of endogenous antigens to MHC-class-I restricted cytotoxic T lymphocytes (CTLs), (iv) stimulatory capacity in allogeneic mixed-lymphocyte cultures (MLCs), (v) sensitivity to natural-killer (NK)-cell-mediated lysis. Co-culture of EBV-positive BL cells with CD40-ligand-transfected L cells induced up-regulation of CD54 and CD80 but did not affect the expression of viral genes. In spite of significant up-regulation of TAP1 and TAP2, and increased expression of MHC class I, the BL cells remained unable to present endogenously expressed viral antigens to EBV-specific CTL. However, the up- regulation of adhesion and co-stimulatory molecules was associated with increased stimulatory capacity in MLC and enhanced sensitivity to NK cells. These findings indicate that, while inducing only a modest phenotype shift, cross-linking of CD40 under physiologic conditions may selectively enhance the sensitivity of BL cells to anti-tumor immune responses.

Original languageEnglish
Pages (from-to)772-779
Number of pages8
JournalInternational Journal of Cancer
Volume83
Issue number6
DOIs
Publication statusPublished - 1999

Fingerprint

Burkitt Lymphoma
Human Herpesvirus 4
Cell Line
Up-Regulation
Viral Antigens
Cytotoxic T-Lymphocytes
Phenotype
Natural Killer Cells
Lymphocytes
CD40 Ligand
Viral Genes
Antigen Presentation
Coculture Techniques
Neoplasms
T-Lymphocytes
Antigens
Genes

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

CD40 cross-linking enhances the immunogenicity of Burkitt's-lymphoma cell lines. / Frisan, Teresa; Donati, Daria; Cervenák, L.; Wilson, Julia; Masucci, Maria Grazia; Bejarano, Maria Teresa.

In: International Journal of Cancer, Vol. 83, No. 6, 1999, p. 772-779.

Research output: Article

Frisan, Teresa ; Donati, Daria ; Cervenák, L. ; Wilson, Julia ; Masucci, Maria Grazia ; Bejarano, Maria Teresa. / CD40 cross-linking enhances the immunogenicity of Burkitt's-lymphoma cell lines. In: International Journal of Cancer. 1999 ; Vol. 83, No. 6. pp. 772-779.
@article{a08d5c0eca304132837a812241a91f30,
title = "CD40 cross-linking enhances the immunogenicity of Burkitt's-lymphoma cell lines",
abstract = "Epstein-Barr-virus (EBV)-positive Burkitt's-lymphoma (BL) cell lines are not recognized by EBV-specific T cells, due to their non-immunogenic phenotype and restricted expression of latent EBV genes. We tested whether triggering of CD40 can alter the phenotype of the tumor cells with regard to: (i) expression of surface markers, (ii) expression of viral antigens, (iii) presentation of endogenous antigens to MHC-class-I restricted cytotoxic T lymphocytes (CTLs), (iv) stimulatory capacity in allogeneic mixed-lymphocyte cultures (MLCs), (v) sensitivity to natural-killer (NK)-cell-mediated lysis. Co-culture of EBV-positive BL cells with CD40-ligand-transfected L cells induced up-regulation of CD54 and CD80 but did not affect the expression of viral genes. In spite of significant up-regulation of TAP1 and TAP2, and increased expression of MHC class I, the BL cells remained unable to present endogenously expressed viral antigens to EBV-specific CTL. However, the up- regulation of adhesion and co-stimulatory molecules was associated with increased stimulatory capacity in MLC and enhanced sensitivity to NK cells. These findings indicate that, while inducing only a modest phenotype shift, cross-linking of CD40 under physiologic conditions may selectively enhance the sensitivity of BL cells to anti-tumor immune responses.",
author = "Teresa Frisan and Daria Donati and L. Cerven{\'a}k and Julia Wilson and Masucci, {Maria Grazia} and Bejarano, {Maria Teresa}",
year = "1999",
doi = "10.1002/(SICI)1097-0215(19991210)83:6<772::AID-IJC13>3.0.CO;2-G",
language = "English",
volume = "83",
pages = "772--779",
journal = "International Journal of Cancer",
issn = "0020-7136",
publisher = "Wiley-Liss Inc.",
number = "6",

}

TY - JOUR

T1 - CD40 cross-linking enhances the immunogenicity of Burkitt's-lymphoma cell lines

AU - Frisan, Teresa

AU - Donati, Daria

AU - Cervenák, L.

AU - Wilson, Julia

AU - Masucci, Maria Grazia

AU - Bejarano, Maria Teresa

PY - 1999

Y1 - 1999

N2 - Epstein-Barr-virus (EBV)-positive Burkitt's-lymphoma (BL) cell lines are not recognized by EBV-specific T cells, due to their non-immunogenic phenotype and restricted expression of latent EBV genes. We tested whether triggering of CD40 can alter the phenotype of the tumor cells with regard to: (i) expression of surface markers, (ii) expression of viral antigens, (iii) presentation of endogenous antigens to MHC-class-I restricted cytotoxic T lymphocytes (CTLs), (iv) stimulatory capacity in allogeneic mixed-lymphocyte cultures (MLCs), (v) sensitivity to natural-killer (NK)-cell-mediated lysis. Co-culture of EBV-positive BL cells with CD40-ligand-transfected L cells induced up-regulation of CD54 and CD80 but did not affect the expression of viral genes. In spite of significant up-regulation of TAP1 and TAP2, and increased expression of MHC class I, the BL cells remained unable to present endogenously expressed viral antigens to EBV-specific CTL. However, the up- regulation of adhesion and co-stimulatory molecules was associated with increased stimulatory capacity in MLC and enhanced sensitivity to NK cells. These findings indicate that, while inducing only a modest phenotype shift, cross-linking of CD40 under physiologic conditions may selectively enhance the sensitivity of BL cells to anti-tumor immune responses.

AB - Epstein-Barr-virus (EBV)-positive Burkitt's-lymphoma (BL) cell lines are not recognized by EBV-specific T cells, due to their non-immunogenic phenotype and restricted expression of latent EBV genes. We tested whether triggering of CD40 can alter the phenotype of the tumor cells with regard to: (i) expression of surface markers, (ii) expression of viral antigens, (iii) presentation of endogenous antigens to MHC-class-I restricted cytotoxic T lymphocytes (CTLs), (iv) stimulatory capacity in allogeneic mixed-lymphocyte cultures (MLCs), (v) sensitivity to natural-killer (NK)-cell-mediated lysis. Co-culture of EBV-positive BL cells with CD40-ligand-transfected L cells induced up-regulation of CD54 and CD80 but did not affect the expression of viral genes. In spite of significant up-regulation of TAP1 and TAP2, and increased expression of MHC class I, the BL cells remained unable to present endogenously expressed viral antigens to EBV-specific CTL. However, the up- regulation of adhesion and co-stimulatory molecules was associated with increased stimulatory capacity in MLC and enhanced sensitivity to NK cells. These findings indicate that, while inducing only a modest phenotype shift, cross-linking of CD40 under physiologic conditions may selectively enhance the sensitivity of BL cells to anti-tumor immune responses.

UR - http://www.scopus.com/inward/record.url?scp=0032735040&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032735040&partnerID=8YFLogxK

U2 - 10.1002/(SICI)1097-0215(19991210)83:6<772::AID-IJC13>3.0.CO;2-G

DO - 10.1002/(SICI)1097-0215(19991210)83:6<772::AID-IJC13>3.0.CO;2-G

M3 - Article

C2 - 10597194

AN - SCOPUS:0032735040

VL - 83

SP - 772

EP - 779

JO - International Journal of Cancer

JF - International Journal of Cancer

SN - 0020-7136

IS - 6

ER -